New details on US global development, health initiatives unveiled
Science and innovation embraced as key pillars of US approach
The Obama Administration recently unveiled details about its new international development strategy, which in part aims to seize upon US expertise in science and innovation to meet international development targets. Although this embrace of science and innovation is promising, how this commitment will be translated into concrete support for global health research and innovation remains to be seen. As US leaders consider how to make the country's global development efforts more effective, they should unquestionably support and elevate global health science and research.
Read more 
Public hearing highlights FDA's role in global health
On September 23, the FDA hosted a pivotal public hearing to examine its role in regulating and reviewing global health technologies. The hearing was hosted by the agency's newly mandated review group for neglected diseases of the developing world in preparation for a report the group will deliver to Congress next year. The GHTC secretariat and four member organizations were among those who testified at the hearing, offering recommendations for an expansion of the FDA’s effort to advance global health products.
Read more
Agency spotlight: DoD
The Department of Defense (DoD) responds to diseases many Americans may never see up close, but which service personnel stationed in the developing world experience alongside local communities. Study of diseases such as malaria, dengue fever, and smallpox has historically been an important component of DoD’s medical research programs worldwide. In particular, DoD's Walter Reed Army Institute of Research (WRAIR) is among the department's premier biomedical research organizations by leveraging basic research and advanced technology to develop global medical solutions.
Read more about the DoD, WRAIR, and global health research
Photos (top to bottom): Siri Wood, Wendy Stone, Satvir Malhotra
|
 |
|
|
October 2010
UPCOMING EVENTS
October 12, 2010
The Road to Developing an AIDS Vaccine: Lessons Learned in Research and Advocacy
October 21-24, 2010
48th Annual Meeting of the Infectious Diseases Society of America
NEW AND NOTEWORTHY
FDA awards nearly $3 million in TB research grants
NIH joins innovative HIV/AIDS drug patent pool
Leaders highlight innovation and science as key principles to achieve the MDGs and GHTC releases new MDG fact sheet
Johnson & Johnson health program to help women and children worldwide includes research for new treatments
Group releases HIV vaccine strategic plan
MEMBER FOCUS
GHTC members the Aeras Global TB Vaccine Foundation (Aeras) and the PATH Malaria Vaccine Initiative (MVI) recently announced landmark developments in clinical trials. Aeras and its partners announced the start of a Phase II clinical trial of infants with its tuberculosis vaccine candidate in Kenya. MVI also announced that researchers have launched Phase III clinical trials for its malaria vaccine candidate.
Read more |
|
Received this as a forward? Click here to sign up for future issues.
If you wish to unsubscribe, please click here to send us a message. We will remove your name from our mailing list as soon as possible.
The Global Health Technologies Coalition (GHTC) is a group of more than 30 nonprofit organizations working to increase awareness of the urgent need for tools that save lives in the developing world. These tools include new vaccines, drugs, microbicides, diagnostic tests, and other devices. The coalition advocates for increased and effective use of public resources, incentives to encourage private investment, and improved regulatory systems. Learn more at www.ghtcoalition.org.
To see a list of GHTC members, click here.
We respect the privacy of our online relationships. our mailing lists are never sold to third parties. We will only share personally identifiable information with third parties when the person submitting the information authorizes us to share it or we are required to by law. |